Abstract
Patients with rheumatic disorders treated with TNF inhibitors are at increased risk of developing TB. There is no ‘gold-standard’ for the diagnosis of latent TB prior to initiation of biologic agents. We report our own experience of comparing two interferon gamma release assays (IGRAs) in screening for latent TB in a ‘high-risk’ TB area in patients with rheumatic disorders. The study demonstrated good concordance between the two tests. We believe the additional cost of these assays is justified in high-risk populations prior to biologic agents, with 16 % of the current study population with at least one positive IGRA assay.
References
Ding T, Ledingham J, Luqmani R et al (2010) BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies. Rheumatology (Oxford) 49(11):2217–2219
Sing JA, Furst DE, Bharat A et al (2012) 2012 update of the 2008 American college of rheumatology recommendations for the use of disease modifying anti-rheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthr Care Res 64(5):625–639
Anderson L, Moore J, Kruijshaar M et al (2010) Tuberculosis in the UK: Report on tuberculosis surveillance in the UK. Health Protection Agency Centre for Infections, London
Melath S, Ahmed A, Marchant-Smith R, Steuer A (2011) The ELISPOT Assay as a screening tool for latent TB in patients with inflammatory arthritis prior to biologic therapy. Ann Rheum Dis 70(Suppl 3):419
Greveson K, Murray C, Toumpanakis C, Epstein O, Hamilton M, Lipman M (2011) Interferon γ-release assays for detecting latent tuberculosis infection in patients scheduled for anti-TNFα therapy. Frontline Gastroenterol 2:26–31
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Melath, S., Ismajli, M., Smith, R. et al. Screening for latent TB in patients with rheumatic disorders prior to biologic agents in a ‘high-risk’ TB population: comparison of two interferon gamma release assays. Rheumatol Int 34, 149–150 (2014). https://doi.org/10.1007/s00296-012-2641-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-012-2641-8